![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: CD55 (CAeditome ID:1604) |
Gene summary for CD55 |
![]() |
Gene information | Gene symbol | CD55 | Gene ID | 1604 |
Gene name | CD55 molecule (Cromer blood group) | |
Synonyms | CHAPLE|CR|CROM|DAF|TC | |
Cytomap | 1q32.2 | |
Type of gene | protein-coding | |
Description | complement decay-accelerating factorCD55 antigenCD55 molecule, decay accelerating factor for complement (Cromer blood group)Cromer blood group antigenRh blood group D antigen | |
Modification date | 20210518 | |
UniProtAcc | P08174 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
CD55 | GO:0030449 | Complement decay-accelerating factor | 25284781 |
CD55 | GO:1903659 | Complement decay-accelerating factor | 25284781 |
CD55 | GO:0001618 | Complement decay-accelerating factor | 7525274 |
CD55 | GO:0008289 | Complement decay-accelerating factor | 12731067 |
CD55 | GO:0002726 | Complement decay-accelerating factor | 16818763 |
CD55 | GO:0007204 | Complement decay-accelerating factor | 8223854 |
CD55 | GO:0031664 | Complement decay-accelerating factor | 12731067 |
CD55 | GO:0045916 | Complement decay-accelerating factor | 6211481 |
CD55 | GO:2000516 | Complement decay-accelerating factor | 16818763 |
CD55 | GO:2000563 | Complement decay-accelerating factor | 16818763 |
CD55 | GO:0005886 | Complement decay-accelerating factor | 6211481 |
CD55 | GO:0009986 | Complement decay-accelerating factor | 15907827 |
CD55 | GO:0045121 | Complement decay-accelerating factor | 11313396 |
Top |
RNA A-to-I events for CD55 |
![]() |
![]() |
![]() |
![]() |
CAediting_136235(207325154, +), CAediting_136236(207325267, +), CAediting_136237(207329661, +), CAediting_136238(207329697, +), CAediting_136239(207329724, +), CAediting_136240(207337178, +), CAediting_136241(207340409, +), CAediting_136242(207340417, +), CAediting_136243(207340440, +), CAediting_136244(207340505, +), CAediting_136245(207340507, +), CAediting_136246(207340523, +), CAediting_136247(207340542, +), CAediting_136248(207340555, +), CAediting_136249(207340557, +), CAediting_136250(207340607, +), CAediting_136251(207340644, +), CAediting_136252(207340900, +), CAediting_136253(207349373, +), CAediting_136254(207349393, +), |
Top |
RNA editing positional annotations for CD55 using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
CAediting_136241 | chr1_207340409_+ | nonsynonymous SNV | ENST00000314754.11 | c.A1100G | p.Q367R | D | B | N |
CAediting_136241 | chr1_207340409_+ | nonsynonymous SNV | ENST00000367063.5 | c.A1100G | p.Q367R | D | B | N |
CAediting_136242 | chr1_207340417_+ | nonsynonymous SNV | ENST00000314754.11 | c.A1108G | p.M370V | D | B | N |
CAediting_136242 | chr1_207340417_+ | nonsynonymous SNV | ENST00000367063.5 | c.A1108G | p.M370V | D | B | N |
CAediting_136244 | chr1_207340505_+ | nonsynonymous SNV | ENST00000314754.11 | c.A1196G | p.Y399C | D | D | N |
CAediting_136244 | chr1_207340505_+ | nonsynonymous SNV | ENST00000367063.5 | c.A1196G | p.Y399C | D | D | N |
CAediting_136245 | chr1_207340507_+ | nonsynonymous SNV | ENST00000314754.11 | c.A1198G | p.R400G | D | P | N |
CAediting_136245 | chr1_207340507_+ | nonsynonymous SNV | ENST00000367063.5 | c.A1198G | p.R400G | D | P | N |
CAediting_136246 | chr1_207340523_+ | nonsynonymous SNV | ENST00000367063.5 | c.A1214G | p.H405R | D | B | N |
CAediting_136248 | chr1_207340555_+ | nonsynonymous SNV | ENST00000367063.5 | c.A1246G | p.R416G | D | P | N |
CAediting_136250 | chr1_207340607_+ | nonsynonymous SNV | ENST00000367063.5 | c.A1298G | p.K433R | D | B | N |
![]() |
CAeditome ID | Position | Variant type |
CAediting_136235 | chr1_207325154_+ | ncRNA_intronic |
CAediting_136236 | chr1_207325267_+ | ncRNA_intronic |
CAediting_136237 | chr1_207329661_+ | ncRNA_intronic |
CAediting_136238 | chr1_207329697_+ | ncRNA_intronic |
CAediting_136239 | chr1_207329724_+ | ncRNA_intronic |
CAediting_136240 | chr1_207337178_+ | exonic |
CAediting_136241 | chr1_207340409_+ | exonic |
CAediting_136242 | chr1_207340417_+ | exonic |
CAediting_136243 | chr1_207340440_+ | exonic |
CAediting_136244 | chr1_207340505_+ | exonic |
CAediting_136245 | chr1_207340507_+ | exonic |
CAediting_136246 | chr1_207340523_+ | exonic |
CAediting_136247 | chr1_207340542_+ | exonic |
CAediting_136248 | chr1_207340555_+ | exonic |
CAediting_136249 | chr1_207340557_+ | exonic |
CAediting_136250 | chr1_207340607_+ | exonic |
CAediting_136251 | chr1_207340644_+ | exonic |
CAediting_136252 | chr1_207340900_+ | ncRNA_intronic |
CAediting_136253 | chr1_207349373_+ | ncRNA_intronic |
CAediting_136254 | chr1_207349393_+ | ncRNA_intronic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
CAediting_136235 | chr1_207325154_+ | SINE | Alu | AluSz |
CAediting_136236 | chr1_207325267_+ | SINE | Alu | AluSz |
CAediting_136237 | chr1_207329661_+ | SINE | Alu | AluJb |
CAediting_136238 | chr1_207329697_+ | SINE | Alu | AluJb |
CAediting_136239 | chr1_207329724_+ | SINE | Alu | AluJb |
CAediting_136241 | chr1_207340409_+ | SINE | Alu | AluJr |
CAediting_136242 | chr1_207340417_+ | SINE | Alu | AluJr |
CAediting_136243 | chr1_207340440_+ | SINE | Alu | AluJr |
CAediting_136244 | chr1_207340505_+ | SINE | Alu | AluJr |
CAediting_136245 | chr1_207340507_+ | SINE | Alu | AluJr |
CAediting_136246 | chr1_207340523_+ | SINE | Alu | AluJr |
CAediting_136247 | chr1_207340542_+ | SINE | Alu | AluJr |
CAediting_136248 | chr1_207340555_+ | SINE | Alu | AluJr |
CAediting_136249 | chr1_207340557_+ | SINE | Alu | AluJr |
CAediting_136250 | chr1_207340607_+ | SINE | Alu | AluJr |
CAediting_136251 | chr1_207340644_+ | SINE | Alu | AluJr |
CAediting_136252 | chr1_207340900_+ | LINE | L1 | L1MA4A |
CAediting_136253 | chr1_207349373_+ | SINE | Alu | AluSz |
CAediting_136254 | chr1_207349393_+ | SINE | Alu | AluSz |
Top |
RNA A-to-I editing events in the alternative splicing sites for CD55 |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
ES | CAediting_136240 | chr1_207337178_+ | 207337163:207337185 | 3SS | 0+5i | ACAAATGCTTCTGCTACACAGGC | -13.56 | ACAAATGCTTCTGCTGCACAGGC | -14.26 |
IR | CAediting_136240 | chr1_207337178_+ | 207337163:207337185 | 3SS | 0+5i | ACAAATGCTTCTGCTACACAGGC | -13.56 | ACAAATGCTTCTGCTGCACAGGC | -14.26 |
ES | CAediting_136241 | chr1_207340409_+ | 207340390:207340412 | 3SS | 0+1i | GGTTCTCGTCCTGTCACCCAGGC | -9.47 | GGTTCTCGTCCTGTCACCCGGGC | -0.72 |
IR | CAediting_136241 | chr1_207340409_+ | 207340390:207340412 | 3SS | 0+1i | GGTTCTCGTCCTGTCACCCAGGC | -9.47 | GGTTCTCGTCCTGTCACCCGGGC | -0.72 |
MEX_1 | CAediting_136241 | chr1_207340409_+ | 207340390:207340412 | 3SS | 0+1i | GGTTCTCGTCCTGTCACCCAGGC | -9.47 | GGTTCTCGTCCTGTCACCCGGGC | -0.72 |
ES | CAediting_136245 | chr1_207340507_+ | 207340506:207340514 | 5SS | 2+0i | CAGGTGTGT | 6.99 | CGGGTGTGT | 5.31 |
MEX_2 | CAediting_136245 | chr1_207340507_+ | 207340506:207340514 | 5SS | 2+0i | CAGGTGTGT | 6.99 | CGGGTGTGT | 5.31 |
MEX_1 | CAediting_136245 | chr1_207340507_+ | 207340506:207340514 | 5SS | 2+0i | CAGGTGTGT | 6.99 | CGGGTGTGT | 5.31 |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for CD55 |
![]() * The grey color means N/A. |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for CD55 |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for CD55 |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_688081 | chr9_63819627_+ | ENSG00000196352.12 | ENST00000367064 | hsa-miR-4477b | 207360959 | 207360965 | 7mer-m8 | 207360945 | 207360965 | 140 | -5.37 |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for CD55 |
![]() * Click on the image to enlarge it in a new window. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
CAediting_136241 | ENST00000314754.11 | chr1_207340409_+ | -594.50 | -595.10 | -599.90 |
CAediting_136242 | ENST00000314754.11 | chr1_207340417_+ | -597.60 | -595.10 | -599.90 |
CAediting_136243 | ENST00000314754.11 | chr1_207340440_+ | -595.10 | -595.10 | -599.90 |
CAediting_136244 | ENST00000314754.11 | chr1_207340505_+ | -595.40 | -595.10 | -599.90 |
CAediting_136245 | ENST00000314754.11 | chr1_207340507_+ | -597.70 | -595.10 | -599.90 |
CAediting_136241 | ENST00000367063.5 | chr1_207340409_+ | -488.70 | -489.40 | -505.70 |
CAediting_136242 | ENST00000367063.5 | chr1_207340417_+ | -489.60 | -489.40 | -505.70 |
CAediting_136243 | ENST00000367063.5 | chr1_207340440_+ | -489.00 | -489.40 | -505.70 |
CAediting_136244 | ENST00000367063.5 | chr1_207340505_+ | -490.00 | -489.40 | -505.70 |
CAediting_136245 | ENST00000367063.5 | chr1_207340507_+ | -493.60 | -489.40 | -505.70 |
CAediting_136246 | ENST00000367063.5 | chr1_207340523_+ | -489.20 | -489.40 | -505.70 |
CAediting_136247 | ENST00000367063.5 | chr1_207340542_+ | -490.90 | -489.40 | -505.70 |
CAediting_136248 | ENST00000367063.5 | chr1_207340555_+ | -494.10 | -489.40 | -505.70 |
CAediting_136249 | ENST00000367063.5 | chr1_207340557_+ | -490.90 | -489.40 | -505.70 |
CAediting_136250 | ENST00000367063.5 | chr1_207340607_+ | -489.50 | -489.40 | -505.70 |
CAediting_136251 | ENST00000367063.5 | chr1_207340644_+ | -494.80 | -489.40 | -505.70 |
CAediting_136240 | ENST00000367067.7 | chr1_207337178_+ | -453.44 | -448.94 | -453.44 |
CAediting_136240 | ENST00000465534.4 | chr1_207337178_+ | -311.34 | -308.44 | -311.34 |
CAediting_136240 | ENST00000476590.1 | chr1_207337178_+ | -466.34 | -464.04 | -466.34 |
Top |
Relation with ADAR for CD55 |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for CD55 |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for CD55 |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for CD55 |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
CD55 | P08174 | DB00446 | Chloramphenicol | Complement decay-accelerating factor | SmallMoleculeDrug | approved|vet_approved |
Top |
RelatedDiseases for CD55 |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
CD55 | C4538570 | COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY | 2 | UNIPROT |
CD55 | C0014175 | Endometriosis | 1 | CTD_human |
CD55 | C0033680 | Protein-Losing Enteropathies | 1 | CTD_human;GENOMICS_ENGLAND |
CD55 | C0086438 | Hypogammaglobulinemia | 1 | GENOMICS_ENGLAND |
CD55 | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |
CD55 | C0236804 | Amphetamine Addiction | 1 | CTD_human |
CD55 | C0236807 | Amphetamine Abuse | 1 | CTD_human |
CD55 | C0267372 | Primary intestinal lymphangiectasia | 1 | GENOMICS_ENGLAND |
CD55 | C0269102 | Endometrioma | 1 | CTD_human |
CD55 | C0272242 | Complement deficiency disease | 1 | GENOMICS_ENGLAND |